4.6 Article

Palliative Efficacy of High-Dose Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Painful Non-Spine Bone Metastases: A Propensity Score-Matched Analysis

Related references

Note: Only part of the references are listed.
Article Oncology

Phase 2 Clinical Trial of Stereotactic Body Radiation Therapy for Painful Nonspine Bone Metastases

Kei Ito et al.

Summary: This study demonstrated the efficacy of SBRT in pain palliation for patients with nonspinal bone metastases, with some associated complications. Larger randomized trials are needed to confirm these findings, with particular attention to the impact of surgical history on edema.

PRACTICAL RADIATION ONCOLOGY (2021)

Article Oncology

Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort

Bart J. Pielkenrood et al.

Summary: In patients with painful bone metastases, stereotactic body radiation therapy (SBRT) did not significantly improve pain response. Some patients preferred conventional external beam radiation therapy over SBRT, and about one in five patients starting SBRT treatment was unable to complete it.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards

Scott G. Soltys et al.

Summary: This study investigated the tumor control probability (TCP) of spinal metastases treated with stereotactic body radiation therapy (SBRT) in different dose and fractionation schemes. The results showed that spinal SBRT with common fractionation schemes yields 2-year estimates of local control of 82% to 96%. Care should be taken interpreting the results due to heterogeneity in tumor control estimates extracted from literature.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial

Arjun Sahgal et al.

Summary: Stereotactic body radiotherapy at a dose of 24 Gy in two daily fractions was found to be superior to conventional external beam radiotherapy at a dose of 20 Gy in five daily fractions in improving the complete response rate for pain in patients with painful spinal metastasis. This suggests that conformal, image-guided, dose-escalated radiotherapy is appropriate for symptom control in selected patients with painful spinal metastases, highlighting the importance of specialized and multidisciplinary care in end-of-life treatment.

LANCET ONCOLOGY (2021)

Meeting Abstract Oncology

Radiosurgery Compared To External Beam Radiotherapy for Localized Spine Metastasis: Phase III Results of NRG Oncology/RTOG 0631

S. Ryu et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Oncology

Patterns of Intraosseous Recurrence After Stereotactic Body Radiation Therapy for Coxal Bone Metastasis

Kei Ito et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Review Clinical Neurology

Stereotactic body radiotherapy for de novo spinal metastases: systematic review

Zain A. Husain et al.

JOURNAL OF NEUROSURGERY-SPINE (2017)

Article Oncology

Bone Health and Pelvic Radiotherapy

C. E. Higham et al.

CLINICAL ONCOLOGY (2015)

Article Statistics & Probability

Multivariate and Propensity Score Matching Software with Automated Balance Optimization: TheMatchingPackage forR

Jasjeet S. Sekhon

Journal of Statistical Software (2015)

Article Oncology

UPDATE OF THE INTERNATIONAL CONSENSUS ON PALLIATIVE RADIOTHERAPY ENDPOINTS FOR FUTURE CLINICAL TRIALS IN BONE METASTASES

Edward Chow et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Oncology

Clinical features of metastatic bone disease and risk of skeletal morbidity

Robert E. Coleman

CLINICAL CANCER RESEARCH (2006)